Transcat, Inc. (NASDAQ:TRNS) Receives $111.50 Average Target Price from Analysts

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $111.50.

A number of brokerages have weighed in on TRNS. Craig Hallum raised their price objective on Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Northland Securities reaffirmed a "market perform" rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Finally, HC Wainwright dropped their target price on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research report on Wednesday, January 29th.

Remove Ads

Transcat Stock Down 0.7 %

Shares of TRNS stock traded down $0.58 on Friday, hitting $82.23. The stock had a trading volume of 54,843 shares, compared to its average volume of 106,831. The stock's 50 day moving average is $95.03 and its 200-day moving average is $108.75. The firm has a market capitalization of $765.43 million, a price-to-earnings ratio of 44.41 and a beta of 0.68. Transcat has a 52-week low of $73.37 and a 52-week high of $147.12. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the previous year, the company posted $0.56 earnings per share. As a group, research analysts expect that Transcat will post 2.3 earnings per share for the current year.

Insiders Place Their Bets

In other Transcat news, Director Craig D. Cairns purchased 1,200 shares of Transcat stock in a transaction dated Friday, January 31st. The shares were bought at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the transaction, the director now owns 1,910 shares in the company, valued at $147,108.20. This represents a 169.01 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Transcat

Several institutional investors and hedge funds have recently bought and sold shares of TRNS. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Transcat by 24.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,029 shares of the scientific and technical instruments company's stock valued at $1,801,000 after acquiring an additional 3,307 shares during the period. Silvercrest Asset Management Group LLC lifted its holdings in shares of Transcat by 39.7% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 62,892 shares of the scientific and technical instruments company's stock worth $6,650,000 after purchasing an additional 17,859 shares during the last quarter. Royal Bank of Canada boosted its position in Transcat by 328.4% during the 4th quarter. Royal Bank of Canada now owns 173,514 shares of the scientific and technical instruments company's stock valued at $18,348,000 after purchasing an additional 133,013 shares during the period. ProShare Advisors LLC grew its stake in Transcat by 49.1% during the 4th quarter. ProShare Advisors LLC now owns 2,542 shares of the scientific and technical instruments company's stock worth $269,000 after buying an additional 837 shares during the last quarter. Finally, Needham Investment Management LLC increased its position in Transcat by 28.4% in the fourth quarter. Needham Investment Management LLC now owns 50,700 shares of the scientific and technical instruments company's stock worth $5,361,000 after buying an additional 11,200 shares during the period. Institutional investors and hedge funds own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.